Generation Bio Co. is developing siRNA therapeutics for T cell-driven autoimmune diseases using its T cell-selective lipid nanoparticle technology. This innovative delivery system aims to ...
6d
Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases- Lead target ...
New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in agriculture and horticulture. They were developed by researchers at the Martin ...
Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases - Lead target and indication to be announced MY 2025 ...
Multidrug-resistant bacteria pose a major threat to human health. Manipulation of bacterial genes at the transcriptional level is a potential strategy to fight antibiotic-resistant bacterial ...
Researchers at Martin Luther University have developed groundbreaking RNA-based agents that offer high levels of protection ...
New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in ...
AZoLifeSciences on MSN4h
RNA-Based Active Agents Successfully Shield Plants from Cucumber Mosaic VirusNew RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in ...
Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research Session Marlborough, ...
Multidrug-resistant bacteria pose a major threat to human health. Manipulation of bacterial genes at the transcriptional level is a potential strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback